Literature DB >> 23148774

Frequency and burden of headache-related nausea: results from the American Migraine Prevalence and Prevention (AMPP) study.

Richard B Lipton1,2, Dawn C Buse1,2, Jane Saiers3, Kristina M Fanning4, Daniel Serrano4, Michael L Reed4.   

Abstract

BACKGROUND: While nausea is a defining feature of migraine, the association of nausea with other headache features and its influence on the burden of migraine have not been quantified. Population-based data were used to elucidate the relative frequency and burden of migraine-associated nausea in persons with migraine.
METHODS: Participants with episodic migraine who completed the 2009 American Migraine Prevalence and Prevention survey rated their headache-related nausea as occurring none of the time, rarely, <half the time, or ≥half the time with their headaches. They also completed headache symptom severity and occupation/work status questions, the Headache Impact Test-6, and treatment attitude items that were part of the 2009 survey. Regression models that adjusted for both sociodemographic characteristics and symptom severity were used to assess the influence of nausea frequency on outcome measures. Partial and semipartial correlational analyses were used to estimate the influence of nausea alone and in combination with other headache symptoms on headache-related impact.
RESULTS: Among the 6488 respondents with episodic migraine, approximately half (49.5%) reported high-frequency nausea (ie, ≥half the time) with headache. High-frequency nausea was more common in females than males (adjusted odds ratio 1.35, 95% confidence interval 1.26-1.44). Persons with high-frequency nausea, compared with the no/rare or less than half the time nausea groups, reported significantly more headache symptoms and more headache-related impact as measured by the Headache Impact Test-6. High-frequency nausea was also associated with being occupationally disabled or on medical leave, and more self-reported financial burden of headache medications, worry about running out of headache medication(s), and that headache medications interfered with work or school work, household work, and family/leisure activities. Regression-based correlational analyses indicated that nausea contributes significantly and independently to headache-related impact.
CONCLUSIONS: High-frequency migraine-associated nausea is common and is a marker for severe, debilitating migraine. Nausea makes an independent contribution to migraine-associated disability and impact. Management strategies that take nausea into account could reduce the burden of migraine. Nausea is an important target for monitoring and treatment.
© 2012 American Headache Society.

Entities:  

Mesh:

Year:  2012        PMID: 23148774     DOI: 10.1111/j.1526-4610.2012.02292.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  13 in total

Review 1.  The Insula: A "Hub of Activity" in Migraine.

Authors:  David Borsook; Rosanna Veggeberg; Nathalie Erpelding; Ronald Borra; Clas Linnman; Rami Burstein; Lino Becerra
Journal:  Neuroscientist       Date:  2015-08-19       Impact factor: 7.519

Review 2.  What the Gut Can Teach Us About Migraine.

Authors:  Nada Hindiyeh; Sheena K Aurora
Journal:  Curr Pain Headache Rep       Date:  2015-07

3.  Sumatriptan iontophoretic transdermal system: A novel approach to migraine-specific therapy.

Authors:  Jerome Goldstein
Journal:  Neurol Clin Pract       Date:  2014-10

Review 4.  Neurobiology of migraine progression.

Authors:  Wanakorn Rattanawong; Alan Rapoport; Anan Srikiatkhachorn
Journal:  Neurobiol Pain       Date:  2022-06-09

Review 5.  Sumatriptan iontophoretic transdermal system: a review of its use in patients with acute migraine.

Authors:  Karly P Garnock-Jones
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

Review 6.  Why does vomiting stop a migraine attack?

Authors:  Nu Cindy Chai; Robert E Shapiro; Alan M Rapoport
Journal:  Curr Pain Headache Rep       Date:  2013-09

7.  Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution: Impact of Migraine-Associated Nausea and Prior Triptan Use on Efficacy.

Authors:  Richard B Lipton; Pete Schmidt; Hans-Christoph Diener
Journal:  Headache       Date:  2017-04-06       Impact factor: 5.887

8.  Humanistic and economic burden of nausea and vomiting among migraine sufferers.

Authors:  Kavita Gajria; Lulu K Lee; Natalia M Flores; Ernesto Aycardi; Sanjay K Gandhi
Journal:  J Pain Res       Date:  2017-03-24       Impact factor: 3.133

9.  Variants in the CNR1 gene predispose to headache with nausea in the presence of life stress.

Authors:  G Juhasz; E Csepany; M Magyar; A E Edes; N Eszlari; G Hullam; P Antal; G Kokonyei; I M Anderson; J F W Deakin; G Bagdy
Journal:  Genes Brain Behav       Date:  2016-11-23       Impact factor: 3.449

Review 10.  A link between gastrointestinal disorders and migraine: Insights into the gut-brain connection.

Authors:  Sheena K Aurora; Stephen B Shrewsbury; Sutapa Ray; Nada Hindiyeh; Linda Nguyen
Journal:  Headache       Date:  2021-04-01       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.